Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04521894
Overview
Currently, Maximum Standardized Uptake Value (SUVmax) is the most commonly used semi-quantitative parameter in PET/CT, which is used to assess tumor burden of PCa, and thus can be used as an imaging biomarker to assess the degree of malignancy of prostate cancers. However, prior studies mainly focused on the correlation between patients' biochemical recurrence lesions and the PSA levels and Gleason score. There is a lack of research to explore the correlation among primary PCa burden, PSA levels, and the degree of prostate cancer malignancy. The aim of this project is to use 18F-PSMA PET/CT SUVmax to analyze the correlation among primary PCa imaging, and clinical indicators, and to evaluate the predictive value for PCa risk stratification, metastasis risk, and biochemical recurrence.
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
N/A
Contacts
Xiaoyi Duan, Ph.D.
duanxy@xjtu.edu.cn
0086-029-85324741
Zhuonan Wang, Ph.D.
zhuonanwang@xjtufh.edu.cn
0086-029-85324741
ClinicalTrials.gov
NCT04521894Drug / Compound
Help us improve your experience